Renaissance Technologies »

Cidara Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 96k 11.94

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Vertex Pharmaceuticals Incorporated (VRTX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Broadcom (AVGO)
Tesla Motors (TSLA)
Sprouts Fmrs Mkt (SFM)
Franco-Nevada Corporation (FNV)
Apple (AAPL)
Gilead Sciences (GILD)
Exelixis (EXEL)

View all positions for Renaissance Technologies

Top funds holding Cidara Therapeutics

Monashee Investment Management
BVF
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
BlackRock
Geode Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Russell Investments
Tower Research Capital
Manchester Capital Management
Pacifica Partners

View all funds holding Cidara Therapeutics